Celyad Oncology SA (OTC:CLYYF) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of capital increase (shares) Closed: €500,000 raised · €0.2 a share Buyers: CFIP CLYD (UK) Limited (€500,000 for 2,500,000 shares; expected to hold approximately 60.52% of outstanding shares and approximately 68.75% of voting rights); an affiliate of Fortress Investment Group (2,500,000 new shares) Insiders: Fortress, a related party through its shareholding and board representation, is the subscriber; its nominated directors did not take part in the board deliberations or votes. Use of proceeds: Working capital and general corporate purposes | Sep 23, 2026 | US$569,630 |
| Private placement of newly issued ordinary shares Announced: €1M · €0.3 a share Buyers: CFIP CLYD (UK) Limited (€1 million for 3,333,333 newly issued ordinary shares; expected to hold approximately 58.51% of the Company's shares) Insiders: Fortress, a related party of the Company, is the sole subscriber and is expected to hold approximately 58.51% of the shares Use of proceeds: Working capital for general corporate purposes; extend cash runway to mid Q4 2025 | Jul 28, 2025 | US$1.16M |